Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00891995 · ClinicalTrials.gov registry record · Phase 2
Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes
A Phase 2 study, sponsored by Jaeb Center for Health Research.
- Terminated
- Registry status
- Phase 2
- Development phase
- 71
- Enrollment target
NCT00891995 is a Phase 2 study that was terminated before completion, run by Jaeb Center for Health Research. The registered enrollment target is 71 participants.
The verdict
NCT00891995, a Phase 2 study, was terminated before completion, sponsored by Jaeb Center for Health Research.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 71 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if very tight blood glucose control from the onset of Type 1 Diabetes can preserve beta cell function. Study subjects will be randomly assigned to receive either standard diabetes management or intensive diabetes management, which involves several days of closed loop therapy followed by home use of a continuous glucose monitor and insulin pump.
Interventions
- DEVICE Continuous glucose monitor
- DEVICE Closed loop
- DEVICE Home glucose monitoring
- DEVICE Insulin pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00891995
The ClinicalTrials.gov registry entry for NCT00891995 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Continuous glucose monitor is the first listed.
NCT00891995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00891995 about?
NCT00891995 is a clinical study titled "Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes". The purpose of this study is to find out if very tight blood glucose control from the onset of Type 1 Diabetes can preserve beta cell function. Study subjects will be randomly assigned to receive either standard diabetes management or intensive diabetes management, which involves several days of clo...
What is the current status of trial NCT00891995?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 71 participants. The study started on 2010-09. Estimated completion is 2013-10.
What interventions are being tested in trial NCT00891995?
The interventions under investigation include: Continuous glucose monitor (DEVICE), Closed loop (DEVICE), Home glucose monitoring (DEVICE), Insulin pump (DEVICE).
Who is sponsoring clinical trial NCT00891995?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.